BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 24467520)

  • 1. Connective tissue growth factor: a predictor of recurrence after catheter ablation in patients with nonparoxysmal atrial fibrillation.
    Song ZP; Liu X; Zhang DD
    Pacing Clin Electrophysiol; 2014 May; 37(5):630-7. PubMed ID: 24467520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-β1 level and outcome after catheter ablation for nonparoxysmal atrial fibrillation.
    Wu CH; Hu YF; Chou CY; Lin YJ; Chang SL; Lo LW; Tuan TC; Li CH; Chao TF; Chung FP; Liao JN; Chen SA
    Heart Rhythm; 2013 Jan; 10(1):10-5. PubMed ID: 22982967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of biomarkers of inflammation and extracellular matrix turnover on the outcome of atrial fibrillation ablation: importance of matrix metalloproteinase-2 as a predictor of atrial fibrillation recurrence.
    Okumura Y; Watanabe I; Nakai T; Ohkubo K; Kofune T; Kofune M; Nagashima K; Mano H; Sonoda K; Kasamaki Y; Hirayama A
    J Cardiovasc Electrophysiol; 2011 Sep; 22(9):987-93. PubMed ID: 21489023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of catheter ablation in nonparoxysmal atrial fibrillation patients with severe enlarged left atrium and its impact on left atrial structural remodeling.
    Pump A; Di Biase L; Price J; Mohanty P; Bai R; Santangeli P; Mohanty S; Trivedi C; Yan RX; Horton R; Sanchez JE; Zagrodzky J; Bailey S; Gallinghouse GJ; Burkhardt JD; Natale A
    J Cardiovasc Electrophysiol; 2013 Nov; 24(11):1224-31. PubMed ID: 24020717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation.
    Mohanty S; Mohanty P; Di Biase L; Bai R; Pump A; Santangeli P; Burkhardt D; Gallinghouse JG; Horton R; Sanchez JE; Bailey S; Zagrodzky J; Natale A
    J Am Coll Cardiol; 2012 Apr; 59(14):1295-301. PubMed ID: 22464257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of chronic obstructive pulmonary disease on procedural outcomes and quality of life in patients with atrial fibrillation undergoing catheter ablation.
    Gu J; Liu X; Tan H; Zhou L; Jiang W; Wang Y; Liu Y; Gu J
    J Cardiovasc Electrophysiol; 2013 Feb; 24(2):148-54. PubMed ID: 23066893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and significance of very early recurrence of atrial fibrillation after catheter ablation.
    Chang SL; Tsao HM; Lin YJ; Lo LW; Hu YF; Tuan TC; Suenari K; Tai CT; Li CH; Chao TF; Lin YK; Tsai CF; Wu TJ; Chen SA
    J Cardiovasc Electrophysiol; 2011 Nov; 22(11):1193-8. PubMed ID: 21615812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome of catheter ablation in patients with nonparoxysmal atrial fibrillation: results of 3-year follow-up.
    Chao TF; Tsao HM; Lin YJ; Tsai CF; Lin WS; Chang SL; Lo LW; Hu YF; Tuan TC; Suenari K; Li CH; Hartono B; Chang HY; Ambrose K; Wu TJ; Chen SA
    Circ Arrhythm Electrophysiol; 2012 Jun; 5(3):514-20. PubMed ID: 22550126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Predictive Value of Growth Differentiation Factor-15 in Recurrence of Atrial Fibrillation after Catheter Ablation.
    Wei Y; Liu S; Yu H; Zhang Y; Gao W; Cui M; Li L
    Mediators Inflamm; 2020; 2020():8360936. PubMed ID: 32904560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of catheter ablation in patients with atrial fibrillation originating from nonpulmonary vein ectopy.
    Chang HY; Lo LW; Lin YJ; Chang SL; Hu YF; Li CH; Chao TF; Chung FP; Ha TL; Singhal R; Chong E; Yin WH; Tsao HM; Hsieh MH; Chen SA
    J Cardiovasc Electrophysiol; 2013 Mar; 24(3):250-8. PubMed ID: 23210627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between left atrial appendage emptying velocity, N-terminal plasma brain natriuretic peptide levels, and recurrence of atrial fibrillation after catheter ablation.
    Ma XX; Zhang YL; Hu B; Jiang WJ; Wang M; Zheng DY; Zhu MR; Xue XP
    J Interv Card Electrophysiol; 2017 Apr; 48(3):343-350. PubMed ID: 27943042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up after catheter ablation of paroxysmal atrial fibrillation: the incidence of recurrence and progression of atrial fibrillation.
    Takigawa M; Takahashi A; Kuwahara T; Okubo K; Takahashi Y; Watari Y; Takagi K; Fujino T; Kimura S; Hikita H; Tomita M; Hirao K; Isobe M
    Circ Arrhythm Electrophysiol; 2014 Apr; 7(2):267-73. PubMed ID: 24610740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-Atrial Dyssynchrony During Sinus Rhythm Predicts Recurrence After the First Catheter Ablation for Atrial Fibrillation.
    Ciuffo L; Tao S; Gucuk Ipek E; Zghaib T; Balouch M; Lima JAC; Nazarian S; Spragg DD; Marine JE; Berger RD; Calkins H; Ashikaga H
    JACC Cardiovasc Imaging; 2019 Feb; 12(2):310-319. PubMed ID: 29361492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Normal Thyroid-Stimulating Hormone Shows a Potential Causal Association With Arrhythmia Recurrence After Catheter Ablation of Atrial Fibrillation.
    Morishima I; Okumura K; Morita Y; Kanzaki Y; Takagi K; Yoshida R; Nagai H; Ikai Y; Furui K; Yoshioka N; Tsuboi H; Murohara T
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 30005553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome 4q25 variants and biomarkers of myocardial fibrosis in patients with atrial fibrillation.
    Choi JI; Baek YS; Roh SY; Piccini JP; Kim YH
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1904-1913. PubMed ID: 31393025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated brain natriuretic peptide level in patients undergoing atrial fibrillation ablation: is it a predictor of failed ablation or a mere function of atrial rhythm and rate at a point in time?
    Pillarisetti J; Reddy N; Biria M; Ryschon K; Nagarajan D; Murray C; Atkins D; Bommana S; Reddy MY; DiBiase L; Pimentel R; Berenbom L; Dawn B; Natale A; Lakkireddy D
    J Interv Card Electrophysiol; 2014 Aug; 40(2):161-8. PubMed ID: 24800931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome and risk of recurrence of atrial fibrillation after catheter ablation.
    Tang RB; Dong JZ; Liu XP; Long DY; Yu RH; Kalifa J; Ma CS
    Circ J; 2009 Mar; 73(3):438-43. PubMed ID: 19179774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-related risks of recurrence of atrial fibrillation after ablation: Insights from the Guangzhou Atrial Fibrillation Ablation Registry.
    Deng H; Shantsila A; Guo P; Potpara TS; Zhan X; Fang X; Liao H; Liu Y; Wei W; Fu L; Xue Y; Wu S; Lip GYH
    Arch Cardiovasc Dis; 2019 Mar; 112(3):171-179. PubMed ID: 30683618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of pretreatment with angiotensin-converting enzyme inhibitors with improvement in ablation outcome in atrial fibrillation patients with low left ventricular ejection fraction.
    Mohanty S; Mohanty P; Trivedi C; Gianni C; Bai R; Burkhardt JD; Gallinghouse JG; Horton R; Sanchez JE; Hranitzky PM; Al-Ahmad A; Bailey S; Di Biase L; Natale A
    Heart Rhythm; 2015 Sep; 12(9):1963-71. PubMed ID: 26051531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting factors for atrial fibrillation acute termination during catheter ablation procedures: implications for catheter ablation strategy and long-term outcome.
    Lo LW; Tai CT; Lin YJ; Chang SL; Udyavar AR; Hu YF; Ueng KC; Tsai WC; Tuan TC; Chang CJ; Kao T; Tsao HM; Wongcharoen W; Higa S; Chen SA
    Heart Rhythm; 2009 Mar; 6(3):311-8. PubMed ID: 19251203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.